Alexander Viloria Winnett
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alexander Viloria Winnett has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Rustem F. Ismagilov
California Institute of Technology
20 shared publications - Natasha Shelby
Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA
16 shared publications - Matthew Feaster
Pasadena Public Health Department
12 shared publications - Ying-Ying Goh
Pasadena Public Health Department
11 shared publications - Alyssa M. Carter
California Institute of Technology, Pasadena, California, USA
9 shared publications - Colten Tognazzini
Pasadena Public Health Department
9 shared publications
Latest Publications
- Open Access
- 7 July 2026
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 5 (7) , pgag211
A train-and-assist device that upskills novices to strengthen the workforce and expand diagnostic access
AI and automation technologies are displacing millions of workers across industries in developed countries, while many developing nations continue to grapple with chronically high unemployment. Meanwhile, healthcare laboratories—particularly in resource-limited settings (including rural and community sites within high-income countries)—face acute shortages of trained staff and the high cost of molecular diagnostics. Here, we propose a “train-and-assist” class of devices that aims to both (i) upskill—rather than replace—workers and (ii) expand diagnostic capacity in a cost-effective way. We describe a device that trains and assists laboratory-inexperienced personnel to perform sample-pooling procedures, which enable high-performance molecular testing at lower costs and higher throughput. A 48-participant user study demonstrated that the device enabled both skill acquisition and high-accuracy pooling. A device-validation study using clinical stool specimens demonstrated that device-assisted pooling agreed 100% with individual assays for soil-transmitted helminths, which affect >1.5 billion people worldwide.
- 7 July 2026
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 5 (7) , pgag211
Open AccessA train-and-assist device that upskills novices to strengthen the workforce and expand diagnostic access
AI and automation technologies are displacing millions of workers across industries in developed countries, while many developing nations continue to grapple with chronically high unemployment. Meanwhile, healthcare laboratories—particularly in resource-limited settings (including rural and community sites within high-income countries)—face acute shortages of trained staff and the high cost of molecular diagnostics. Here, we propose a “train-and-assist” class of devices that aims to both (i) upskill—rather than replace—workers and (ii) expand diagnostic capacity in a cost-effective way. We describe a device that trains and assists laboratory-inexperienced personnel to perform sample-pooling procedures, which enable high-performance molecular testing at lower costs and higher throughput. A 48-participant user study demonstrated that the device enabled both skill acquisition and high-accuracy pooling. A device-validation study using clinical stool specimens demonstrated that device-assisted pooling agreed 100% with individual assays for soil-transmitted helminths, which affect >1.5 billion people worldwide.
- Open Access
Early Mucosal Type II Interferon Limits SARS-CoV-2 Replication in Humans
COVID-19 vaccines markedly reduce disease severity, but their ability to block infection and transmission remains limited and variable. 1 A better understanding of early mucosal immune programs that constrain viral replication at susceptible upper respiratory sites is needed to develop more effective antiviral strategies. However, temporal and anatomical antiviral dynamics are difficult to resolve without longitudinal, paired-site sampling beginning before infection onset. We quantified longitudinal viral load by RT-qPCR and human gene expression by mRNA sequencing in 1,237 samples prospectively collected daily from the nasal cavity, oral cavity, and oropharynx of 16 individuals starting from the onset of naturally acquired SARS-CoV-2 infection, and 16 age-, sex-, and vaccination-matched uninfected individuals. Here we show that Type I interferon (IFN) responses are initiated concurrently across these upper respiratory sites, even before local viral detection. In contrast, Type II IFN initiation is more spatially variable, and earlier nasal Type II IFN initiation is associated with reduced viral replication, prior COVID-19 vaccination, and higher tissue-resident memory T cell (T RM ) signature expression. These findings demonstrate that in addition to humoral immunity, prior vaccination primes rapid, inducible mucosal Type II IFN responses, likely mediated by rare T RM upon viral encounter, to limit viral replication and spread. ONE SENTENCE SUMMARY: Using a unique study design with temporally-dense, paired sampling of the oral cavity, nasal cavity and oropharynx from the onset of naturally acquired human SARS-CoV-2 infection, we demonstrate that Type I IFN responses are initiated synchronously in the upper respiratory mucosa during early infection, whereas the timing of Type II IFN response initiation is asynchronous but earlier initiation is associated with prior COVID-19 vaccination, enhanced tissue-resident memory T cells signatures, and reduced local viral replication. Graphical : Among participants who prospectively collected daily, paired specimens from multiple upper respiratory anatomical sites while enrolled in a case-ascertained COVID-19 household transmission study conducted in Los Angeles, California between September 2020 and April 2022, a subset of participants were found to initially be negative upon enrollment but later became positive for SARS-CoV-2. These were defined as Cases of naturally acquired, incident SARS-CoV-2 infection, and for whom age, sex, and prior COVID-19 vaccination status matched Control participants without SARS-CoV-2 infection were identified, and demographic data is shown. Samples underwent viral load quantification by RT-qPCR, validated by RT-ddPCR, and human transcriptome sequencing to calculate immune pathway activation and determine the timing of Type I and II IFN response initiation, and expression of a tissue resident memory T cell (T RM ) signature. Differences in the magnitude and timing of these pathways were compared by vaccination status, and by subsequent viral RNA shedding to identify mucosal immune correlates of reduced viral replication. Created in https://BioRender.com .
Open AccessEarly Mucosal Type II Interferon Limits SARS-CoV-2 Replication in Humans
COVID-19 vaccines markedly reduce disease severity, but their ability to block infection and transmission remains limited and variable. 1 A better understanding of early mucosal immune programs that constrain viral replication at susceptible upper respiratory sites is needed to develop more effective antiviral strategies. However, temporal and anatomical antiviral dynamics are difficult to resolve without longitudinal, paired-site sampling beginning before infection onset. We quantified longitudinal viral load by RT-qPCR and human gene expression by mRNA sequencing in 1,237 samples prospectively collected daily from the nasal cavity, oral cavity, and oropharynx of 16 individuals starting from the onset of naturally acquired SARS-CoV-2 infection, and 16 age-, sex-, and vaccination-matched uninfected individuals. Here we show that Type I interferon (IFN) responses are initiated concurrently across these upper respiratory sites, even before local viral detection. In contrast, Type II IFN initiation is more spatially variable, and earlier nasal Type II IFN initiation is associated with reduced viral replication, prior COVID-19 vaccination, and higher tissue-resident memory T cell (T RM ) signature expression. These findings demonstrate that in addition to humoral immunity, prior vaccination primes rapid, inducible mucosal Type II IFN responses, likely mediated by rare T RM upon viral encounter, to limit viral replication and spread. ONE SENTENCE SUMMARY: Using a unique study design with temporally-dense, paired sampling of the oral cavity, nasal cavity and oropharynx from the onset of naturally acquired human SARS-CoV-2 infection, we demonstrate that Type I IFN responses are initiated synchronously in the upper respiratory mucosa during early infection, whereas the timing of Type II IFN response initiation is asynchronous but earlier initiation is associated with prior COVID-19 vaccination, enhanced tissue-resident memory T cells signatures, and reduced local viral replication. Graphical : Among participants who prospectively collected daily, paired specimens from multiple upper respiratory anatomical sites while enrolled in a case-ascertained COVID-19 household transmission study conducted in Los Angeles, California between September 2020 and April 2022, a subset of participants were found to initially be negative upon enrollment but later became positive for SARS-CoV-2. These were defined as Cases of naturally acquired, incident SARS-CoV-2 infection, and for whom age, sex, and prior COVID-19 vaccination status matched Control participants without SARS-CoV-2 infection were identified, and demographic data is shown. Samples underwent viral load quantification by RT-qPCR, validated by RT-ddPCR, and human transcriptome sequencing to calculate immune pathway activation and determine the timing of Type I and II IFN response initiation, and expression of a tissue resident memory T cell (T RM ) signature. Differences in the magnitude and timing of these pathways were compared by vaccination status, and by subsequent viral RNA shedding to identify mucosal immune correlates of reduced viral replication. Created in https://BioRender.com .
- Open Access
A train-and-assist device that upskills novices to strengthen the workforce and expand diagnostic access
Artificial intelligence and automation technologies are displacing millions of workers across industries in developed countries, while many developing nations continue to grapple with chronically high unemployment. Meanwhile, healthcare laboratories—particularly in resource-limited settings (including rural and community sites within high-income countries)—face acute shortages of trained staff and the high cost of molecular diagnostics. Here, we propose a “train-and-assist” class of devices that aims to both (i) upskill—rather than replace—workers and (ii) expand diagnostic capacity in a cost-effective way. We describe a device that trains and assists laboratory-inexperienced personnel to perform sample-pooling procedures, which enable high-performance molecular testing at lower costs and higher throughput. A 48-participant user study demonstrated that the device enabled both skill acquisition and high-accuracy pooling. A device-validation study using clinical stool specimens demonstrated that device-assisted pooling agreed 100% with individual assays for soil-transmitted helminths, which affect more than 1.5 billion people worldwide. Teaser: We propose a new class of technologies that train and assist personnel to learn skills for complex laboratory tasks, with the goal of strengthening the diagnostics workforce and expanding healthcare access.
Open AccessA train-and-assist device that upskills novices to strengthen the workforce and expand diagnostic access
Artificial intelligence and automation technologies are displacing millions of workers across industries in developed countries, while many developing nations continue to grapple with chronically high unemployment. Meanwhile, healthcare laboratories—particularly in resource-limited settings (including rural and community sites within high-income countries)—face acute shortages of trained staff and the high cost of molecular diagnostics. Here, we propose a “train-and-assist” class of devices that aims to both (i) upskill—rather than replace—workers and (ii) expand diagnostic capacity in a cost-effective way. We describe a device that trains and assists laboratory-inexperienced personnel to perform sample-pooling procedures, which enable high-performance molecular testing at lower costs and higher throughput. A 48-participant user study demonstrated that the device enabled both skill acquisition and high-accuracy pooling. A device-validation study using clinical stool specimens demonstrated that device-assisted pooling agreed 100% with individual assays for soil-transmitted helminths, which affect more than 1.5 billion people worldwide. Teaser: We propose a new class of technologies that train and assist personnel to learn skills for complex laboratory tasks, with the goal of strengthening the diagnostics workforce and expanding healthcare access.
- Open Access
Faecalibacterium prausnitzii , depleted in the Parkinson’s disease microbiome, improves motor deficits in α-synuclein overexpressing mice
Gut microbiome composition is altered in Parkinson’s disease (PD), a neurodegenerative disorder characterized by motor dysfunction and frequently accompanied by gastrointestinal (GI) symptoms. Notably, microbial taxa with anti-inflammatory properties are consistently depleted in PD patients compared to controls. To explore whether specific gut bacteria may be disease-protective, we assembled a microbial consortium of 8 human-associated taxa that are reduced in individuals with PD across multiple cohorts and geographies. Treatment of α-synuclein overexpressing (Thy1-ASO) mice, an animal model of PD, with this consortium improved motor and GI deficits. A single bacterial species from this consortium, Faecalibacterium prausnitzii , was sufficient to correct gut microbiome deviations in Thy1-ASO mice, induce anti-inflammatory immune responses, and promote protective colonic gene expression profiles. Accordingly, oral treatment with F. prausnitzii robustly ameliorated motor and GI symptoms and reduced α-synuclein aggregates in the brain. These findings support the emerging hypothesis of functional contributions by the microbiome to PD and embolden development of potential probiotic therapies.
Open AccessFaecalibacterium prausnitzii , depleted in the Parkinson’s disease microbiome, improves motor deficits in α-synuclein overexpressing mice
Gut microbiome composition is altered in Parkinson’s disease (PD), a neurodegenerative disorder characterized by motor dysfunction and frequently accompanied by gastrointestinal (GI) symptoms. Notably, microbial taxa with anti-inflammatory properties are consistently depleted in PD patients compared to controls. To explore whether specific gut bacteria may be disease-protective, we assembled a microbial consortium of 8 human-associated taxa that are reduced in individuals with PD across multiple cohorts and geographies. Treatment of α-synuclein overexpressing (Thy1-ASO) mice, an animal model of PD, with this consortium improved motor and GI deficits. A single bacterial species from this consortium, Faecalibacterium prausnitzii , was sufficient to correct gut microbiome deviations in Thy1-ASO mice, induce anti-inflammatory immune responses, and promote protective colonic gene expression profiles. Accordingly, oral treatment with F. prausnitzii robustly ameliorated motor and GI symptoms and reduced α-synuclein aggregates in the brain. These findings support the emerging hypothesis of functional contributions by the microbiome to PD and embolden development of potential probiotic therapies.
- Open Access
- 5 August 2025
- Published by MIT Science Policy Review
- Vol. 6, 36-59
A decennial review of health disparities among the growing Bi+ population in the United States
Nearly 14 million individuals in the United States (U.S.) currently identify as Bi+ (bisexual, pansexual and other terms), and this segment of the population–5.2% of adults–is growing each year. Yet, marginalization by monosexual (i.e., heterosexual and homosexual) communities has resulted in significant health disparities for Bi+ populations. With a focus on research that has emerged in the past decade, this review describes current conceptualizations of the mechanisms underlying Bi+ health disparities and available high-quality evidence for Bi+ health disparities related to healthcare access, mental health, diagnosis and prevention of HIV and Mpox virus, and other physical health conditions. As the Bi+ population includes substantial racial/ethnic and gender diversity, we discuss the intersection and nuanced effect of these demographic factors on Bi+ health disparities. Findings from this decennial Review reveal challenges and opportunities for policies to reduce health disparities among the rapidly growing Bi+ population in the U.S.
- 5 August 2025
- Published by MIT Science Policy Review
- Vol. 6, 36-59
Open AccessA decennial review of health disparities among the growing Bi+ population in the United States
Nearly 14 million individuals in the United States (U.S.) currently identify as Bi+ (bisexual, pansexual and other terms), and this segment of the population–5.2% of adults–is growing each year. Yet, marginalization by monosexual (i.e., heterosexual and homosexual) communities has resulted in significant health disparities for Bi+ populations. With a focus on research that has emerged in the past decade, this review describes current conceptualizations of the mechanisms underlying Bi+ health disparities and available high-quality evidence for Bi+ health disparities related to healthcare access, mental health, diagnosis and prevention of HIV and Mpox virus, and other physical health conditions. As the Bi+ population includes substantial racial/ethnic and gender diversity, we discuss the intersection and nuanced effect of these demographic factors on Bi+ health disparities. Findings from this decennial Review reveal challenges and opportunities for policies to reduce health disparities among the rapidly growing Bi+ population in the U.S.
- Open Access
- 1 February 2025
- Published by Microbiology Society in Access Microbiology
- Vol. 7 (2) , 000732.v3
The ratio between SARS-CoV-2 RNA viral load and culturable viral titre differs depending on the stage of infection: a case study of household transmission in an adult male
Effective public health measures for communicable diseases rely on the ability to identify infectious individuals and prevent transmission from those individuals. For severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the presence of replication-competent virus in specimens from an individual is the gold standard for confirming infectiousness. However, viral culture from clinical specimens is difficult and infrequently performed. Instead, infectiousness may be inferred based on the abundance of viral RNA (or viral load) in a specimen, which is more easily assessed. For this reason, understanding the relationship between RNA viral load and infectious viral titre has important implications for public health strategy. In this case report, we quantified incident, longitudinal SARS-CoV-2 viral loads collected from saliva and nasal-swab specimens, and viral titre from nasal-swab specimens. We observed that the relationship between viral load and viral titre decreases by over five orders of magnitude throughout the course of the infection. Our work demonstrates the potential for infectious virus even in specimens with low viral loads collected during the early phases of infection.
- 1 February 2025
- Published by Microbiology Society in Access Microbiology
- Vol. 7 (2) , 000732.v3
Open AccessThe ratio between SARS-CoV-2 RNA viral load and culturable viral titre differs depending on the stage of infection: a case study of household transmission in an adult male
Effective public health measures for communicable diseases rely on the ability to identify infectious individuals and prevent transmission from those individuals. For severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the presence of replication-competent virus in specimens from an individual is the gold standard for confirming infectiousness. However, viral culture from clinical specimens is difficult and infrequently performed. Instead, infectiousness may be inferred based on the abundance of viral RNA (or viral load) in a specimen, which is more easily assessed. For this reason, understanding the relationship between RNA viral load and infectious viral titre has important implications for public health strategy. In this case report, we quantified incident, longitudinal SARS-CoV-2 viral loads collected from saliva and nasal-swab specimens, and viral titre from nasal-swab specimens. We observed that the relationship between viral load and viral titre decreases by over five orders of magnitude throughout the course of the infection. Our work demonstrates the potential for infectious virus even in specimens with low viral loads collected during the early phases of infection.
- Open Access
- 17 January 2025
- Published by Microbiology Society
- p. 000732.v2
The ratio between SARS-CoV-2 RNA viral load and culturable viral titer differs depending on stage of infection: case study of household transmission in an adult male
Effective public health measures for communicable diseases rely on the ability to identify infectious individuals and prevent transmission from those individuals. For SARS-CoV-2, the presence of replication-competent virus in specimens from an individual is the gold standard for confirming infectiousness. However, viral culture from clinical specimens is difficult and infrequently performed. Instead, infectiousness may be inferred based on the abundance of viral RNA (or viral load) in a specimen, which is more easily assessed. For this reason, understanding the relationship between RNA viral load and infectious viral titer has important implications for public health strategy. In this case report, we quantified incident, longitudinal SARS-CoV-2 viral loads collected from saliva and nasal-swab specimens, and viral titer from nasal-swab specimens. We observed that the relationship between viral load and viral titer decreases by over five orders of magnitude throughout the course of the infection. Our work demonstrates the potential for infectious virus even in specimens with low viral loads collected during the early phases of infection.
- 17 January 2025
- Published by Microbiology Society
- p. 000732.v2
Open AccessThe ratio between SARS-CoV-2 RNA viral load and culturable viral titer differs depending on stage of infection: case study of household transmission in an adult male
Effective public health measures for communicable diseases rely on the ability to identify infectious individuals and prevent transmission from those individuals. For SARS-CoV-2, the presence of replication-competent virus in specimens from an individual is the gold standard for confirming infectiousness. However, viral culture from clinical specimens is difficult and infrequently performed. Instead, infectiousness may be inferred based on the abundance of viral RNA (or viral load) in a specimen, which is more easily assessed. For this reason, understanding the relationship between RNA viral load and infectious viral titer has important implications for public health strategy. In this case report, we quantified incident, longitudinal SARS-CoV-2 viral loads collected from saliva and nasal-swab specimens, and viral titer from nasal-swab specimens. We observed that the relationship between viral load and viral titer decreases by over five orders of magnitude throughout the course of the infection. Our work demonstrates the potential for infectious virus even in specimens with low viral loads collected during the early phases of infection.
- Open Access
- 23 July 2024
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 79 (4) , 815-818
Validating Combination Throat-Nasal Swab Specimens for Coronavirus Disease 2019 Tests Would Improve Early Detection, Especially for the Most Vulnerable
Early detection of severe acute respiratory syndrome coronavirus 2 infection by diagnostic tests can prompt actions to reduce transmission and improve treatment efficacy, especially for vulnerable groups such as immunocompromised individuals. Recent evidence suggests that sampling the throat in addition to the nose improves clinical sensitivity during early infection for both antigen and molecular coronavirus disease 2019 tests. We urge test manufacturers to validate tests for use with throat swab, in combination with nasal swabs.
- 23 July 2024
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 79 (4) , 815-818
Open AccessValidating Combination Throat-Nasal Swab Specimens for Coronavirus Disease 2019 Tests Would Improve Early Detection, Especially for the Most Vulnerable
Early detection of severe acute respiratory syndrome coronavirus 2 infection by diagnostic tests can prompt actions to reduce transmission and improve treatment efficacy, especially for vulnerable groups such as immunocompromised individuals. Recent evidence suggests that sampling the throat in addition to the nose improves clinical sensitivity during early infection for both antigen and molecular coronavirus disease 2019 tests. We urge test manufacturers to validate tests for use with throat swab, in combination with nasal swabs.
- Open Access
Efficient and accurate detection of viral sequences at single-cell resolution reveals putative novel viruses perturbing host gene expression
More than 300,000 mammalian virus species are estimated to cause disease in humans. They inhabit human tissues such as the lungs, blood, and brain and often remain undetected. Efficient and accurate detection of viral infection is vital to understanding its impact on human health and to make accurate predictions to limit adverse effects, such as future epidemics. The increasing use of high-throughput sequencing methods in research, agriculture, and healthcare provides an opportunity for the cost-effective surveillance of viral diversity and investigation of virus-disease correlation. However, existing methods for identifying viruses in sequencing data rely on and are limited to reference genomes or cannot retain single-cell resolution through cell barcode tracking. We introduce a method that accurately and rapidly detects viral sequences in bulk and single-cell transcriptomics data based on highly conserved amino acid domains, which enables the detection of RNA viruses covering up to 1012 virus species. The analysis of viral presence and host gene expression in parallel at single-cell resolution allows for the characterization of host viromes and the identification of viral tropism and host responses. We applied our method to identify novel viruses in rhesus macaque PBMC data that display cell type specificity and whose presence correlates with altered host gene expression.
Open AccessEfficient and accurate detection of viral sequences at single-cell resolution reveals putative novel viruses perturbing host gene expression
More than 300,000 mammalian virus species are estimated to cause disease in humans. They inhabit human tissues such as the lungs, blood, and brain and often remain undetected. Efficient and accurate detection of viral infection is vital to understanding its impact on human health and to make accurate predictions to limit adverse effects, such as future epidemics. The increasing use of high-throughput sequencing methods in research, agriculture, and healthcare provides an opportunity for the cost-effective surveillance of viral diversity and investigation of virus-disease correlation. However, existing methods for identifying viruses in sequencing data rely on and are limited to reference genomes or cannot retain single-cell resolution through cell barcode tracking. We introduce a method that accurately and rapidly detects viral sequences in bulk and single-cell transcriptomics data based on highly conserved amino acid domains, which enables the detection of RNA viruses covering up to 1012 virus species. The analysis of viral presence and host gene expression in parallel at single-cell resolution allows for the characterization of host viromes and the identification of viral tropism and host responses. We applied our method to identify novel viruses in rhesus macaque PBMC data that display cell type specificity and whose presence correlates with altered host gene expression.
- Open Access
- 3 November 2023
- Published by Microbiology Society
- p. 000732.v1
The ratio between SARS-CoV-2 RNA viral load and culturable viral titer differs depending on stage of infection
Analysis of incident, longitudinal RNA viral loads in saliva and nasal swabs and culturable viral titers in nasal swabs collected twice-daily by a tricenarian male infected with SARS-CoV-2 revealed the ratio between viral load and viral titer can be five orders of magnitude higher during early infection than late infection.
- 3 November 2023
- Published by Microbiology Society
- p. 000732.v1
Open AccessThe ratio between SARS-CoV-2 RNA viral load and culturable viral titer differs depending on stage of infection
Analysis of incident, longitudinal RNA viral loads in saliva and nasal swabs and culturable viral titers in nasal swabs collected twice-daily by a tricenarian male infected with SARS-CoV-2 revealed the ratio between viral load and viral titer can be five orders of magnitude higher during early infection than late infection.